target and capturing

Scil Proteins Production to join WACKER creating leading microbial-based biopharmaceutical manufacturer

Halle, Germany, 12th November 2013 - Scil Proteins Production, a private contract manufacturer of recombinant proteins, today announced that Wacker Biotech GmbH, a subsidiary of Wacker Chemie AG, has acquired 100% of its shares from the sole holder in the company, BioNet Ventures GmbH. The transaction is expected to close at the beginning of 2014. Both companies are committed to a seamless transfer of business assets, as well as a smooth transition for the employees to WACKER.